Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs

W. H. Hsiang, J. B. Jiang, L. F. Liu

研究成果: 雜誌貢獻文章同行評審

99 引文 斯高帕斯(Scopus)


Treatment of SV40-infected monkey cells with amonafide (benzisoquinolinedione), an intercalative antitumor drug, resulted in rapid accumulation of linearized intracellular SV40 DNA molecules that were protein linked. Studies using purified mammalian DNA topoisomerase II have shown that amonafide and its structural analogs interfere with the breakage-rejoining reaction of the enzyme by stabilizing a reversible enzyme-DNA 'cleavable complex'. Denaturation of the cleavable complex with sodium dodecyl sulfate resulted in DNA cleavage and the covalent association of topoisomerase II polypeptides with the cleaved DNA. Unwinding measurements indicate that amonafide is a DNA intercalator. These results suggest that amonafide and its structural analogs (e.g., mitonafide) represent a new class of intercalative topoisomerase II-active antitumor drugs. Different from other topoisomerase II-active antitumor drugs, amonafide and mitonafide induce specific DNA cleavage at a single major site on pBR322 DNA. The strong site specificity of amonafide may allow detailed characterization of the intercalator-stabilized, topoisomerase II-DNA cleavable complex.

頁(從 - 到)371-376
期刊Molecular Pharmacology
出版狀態已發佈 - 1989

ASJC Scopus subject areas

  • 分子醫學
  • 藥理


深入研究「Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs」主題。共同形成了獨特的指紋。